1. Home
  2. > Healthcare
  3. > Pathology Market Trends
Vaccines Market by Technology, Type, Disease, Route of Administration, End user - Global Forecast to 2026

Vaccines Market by Technology, Type, Disease, Route of Administration, End user - Global Forecast to 2026

  • January 2022
  • 293 pages
  • ID: 5073750
  • Format: PDF
  • MarketsandMarkets

Summary

Table of Contents

Search Inside

The global vaccines market (including COVID-19 vaccines) is projected to reach USD 149.2billion by 2026 from USD 139.4 billion in 2021 during the forecast period. The global vaccines market (excluding COVID-19 vaccines) is projected to reach USD 67.2billion by 2026 from USD 41.4 billion in 2021, at a CAGR of 10.2% from 2021 to 2026. Market growth is largely driven by the rise of emerging and re-emerging infectious diseases, increasing company initiatives to enhance vaccine R&D, growing government support for vaccine development, and the rising focus on immunization. However, the huge capital investments required for developing vaccines and low purchasing power in developing countries may restrain the market growth.

Conjugate vaccines segment accounted for the largest share of the technology segment (excluding COVID 19 vaccines)
Based on technology, the vaccines market (excluding COVID 19 vaccines) has been segmented into conjugate vaccines, recombinant vaccines, inactivated & subunit vaccines, live attenuated vaccines, toxoid vaccines, and viral vector vaccines.The conjugate vaccines segment accounted for the largest share of the global vaccines market (excluding COVID-19 vaccines), by technology, in 2020.

The large share of this segment can be attributed to the increasing government support and rising company investments in conjugate vaccine development.

The Pneumococcal disease segment accounted for the largest share in 2020
Based on disease indication, the vaccines market is segmented into pneumococcal disease, influenza, combination vaccines, HPV, meningococcal disease, herpes zoster, rotavirus, MMR, varicella, hepatitis, DTP, polio, COVID-19, and other disease indications.The pneumococcal disease segment accounted for the largest share of the vaccines market, by disease indication, in 2020.

The large share of this segment is attributed to the high incidence of pneumococcal disease and increasing government investments in pneumococcal vaccination programs.

Monovalent vaccines segment accounted for the largest share of the type segment
Based on type, the global vaccines market is segmented into monovalent and multivalent vaccines.The monovalent vaccines segment accounted for the largest share of the global vaccines market (excluding COVID-19 vaccines) in 2020.

Growing disease prevalence has prompted initiatives for immunization against specific infectious diseases such as COVID 19.This has led to large market share for monovalent vaccines.

Rising prevalence of emerging and re-emerging infectious diseases and R&D initiatives will contrive to drive the market for monovalent vaccines.

Pediatric vaccines segment accounted for the largest share of the end user segment
Based on end user, the global vaccines market is segmented into pediatric and adult users.In 2020, the pediatric users segment accounted for the largest share the vaccines market (excluding COVID 19 vaccines), while the adult user segment is estimated to register the highest CAGR during the forecast period.

Increased initiatives from government and non-government organizations and increasing company initiatives to develop advanced pediatric vaccines for preventing diseases are expected to drive market growth for pediatric vaccines.
Intramuscular & Subcutaneous route of administration segment accounted for the largest share of the route of administration segment
Based on the route of administration, the vaccines market is segmented into intramuscular and subcutaneous administration, oral administration, and other routes of administration.In 2020, the intramuscular and subcutaneous administration segment accounted for the largest share of the vaccines market (excluding COVID-19 vaccines).

Intramuscular & Subcutaneous is one of the most prevalent route of administration for vaccines due to its precise control of dose and administration rate, rapid exposure to antigen, and ease of administration.

North America was the largest regional market for Vaccines market in 2020
Based on the region, the vaccines market is broadly segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.North America accounted for the largest share of the vaccines market in 2020.

The high prevalence of infectious diseases, increasing investments by government organizations for vaccine development, increasing R&D investments by market players, and mandatory reporting are some of the key factors driving the vaccines market in North America.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80%and Demand Side 20%
• By Designation: Managers - 55%, CXOs - 20%, and Executives - 25%
• By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

Lists of Companies Profiled in the Report:
• GlaxoSmithKline Plc (UK)
• Merck & Co., Inc. (US)
• Pfizer, Inc. (US)
• Sanofi SA (France)
• CSL Limited (Australia)
• Emergent BioSolutions, Inc. (US)
• Johnson & Johnson (US)
• AstraZeneca Plc (UK)
• Serum Institute of India Pvt. Ltd. (India)
• Bavarian Nordic A/S (Denmark)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Daiichi Sankyo Company, Limited (Japan)
• Panacea Biotec, Ltd. (India)
• Biological E. Limited (India)
• Bharat Biotech Ltd. (India)
• Novavax, Inc. (US)
• FSUE NPO Microgen (Russia)
• Sinovac Biotech, Ltd. (China)
• Incepta Vaccine Limited (Bangladesh)
• Valneva SE (France), VBI Vaccines (US)
• PT Bio Frama (Persero) (Indonesia)
• Inovio Pharmaceuticals, Inc. (US)
• Chongqing Zhifei Biological Products Co. Ltd. (China)
• Indian Immunologicals Limited (India)

Research Coverage:
This report provides a detailed picture of the vaccines market.It aims at estimating the size and future growth potential of the market across different segments such as thetechnology, type, disease indication, route of administration, end-user and region.

The report also includes an in-depth competitive analysis ofthe key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall vaccines marketand its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers,restraints,trends,challenges and opportunities.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

GMP Testing Service Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Service Type and End User

  • $ 4550
  • September 2022
  • 250 pages

The GMP testing service market is expected to grow from US$ 1,830.57 million in 2021 to US$ 2,863.42 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2022 to 2028. The report highlights ...

  • World
  • APAC
  • Pharmaceutical
  • Biopharmaceutical
  • Industry analysis
  • Health Expenditure
  • Pharmaceutical Production

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on